π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This study is a prospective, single-center, open-label, umbrella-shaped pha...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-05-01
Trial ID
NCT04355858
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
The study is being conducted to evaluate the tolerability, safety and effic...
Status
Completed
Location
Beijing Cancer Hosptial
Start Date
2019-06-04
Trial ID
NCT03945604
Treatments Being Tested
This study is a prospective, multi-cohort, single-centre, phase II clinical...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06055166
The purpose of this study is to evaluate how well fuzoparib in combination ...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-08-15
Trial ID
NCT05983237
Treatments Being Tested
The purpose of this study is to establish a prospective, multi-center platf...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2022-12-30
Trial ID
NCT05594095
This study is planned to include 80 patients with HRD positive HER2-negativ...
Status
Suspended
Location
Sun-yat sen university cancer center
Start Date
2022-11-23
Trial ID
NCT05656131
Treatments Being Tested
This is a Phase II, Open, Single-center Study of Camrelizumab and Fluzopari...
Status
Unknown
Location
Multiple Locations
Start Date
2021-05-06
Trial ID
NCT04782089
Treatments Being Tested
The study consists of the two parts, the first one is SHR7390 combined with...
Status
Terminated
Location
The Cancer Center,Sun Yat-sen University
Start Date
2017-07-24
Trial ID
NCT03182673
To explore the efficacy and safety of TROP2 in the treatment of ABC...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05928780
Treatments Being Tested